Please note that we have amended our general terms and conditions. Please click here to read the amended WALLESS general terms and conditions, which became effective as of 1 November 2021.
Please note that we have amended our general terms and conditions. Please click here to read the amended WALLESS general terms and conditions, which became effective as of 1 November 2021.

WALLESS Assisted Affidea with Acquisition of Medicinos Paslaugų Grupė

With the help of WALLESS, Affidea has successfully completed the acquisition of UAB Medicinos Paslaugų Grupė (MPG) expanding its presence in Lithuania from 11 to 23 centers. WALLESS team advised on the legal matters of the purchase of the shares from LitCapital I KŪB fund. With this investment, Affidea’s network in Lithuania has grown to provide medical care to over 250 000 patients every year and to employ over 420 dedicated health professionals out of whom approximately 200 are coming from MPG. Affidea is the leading provider of diagnostic imaging, outpatient and cancer care services announces in Europe, operating in 16 countries. MPG is an important private healthcare service provider in Lithuania, with a wide network of 12 outpatient and diagnostic imaging clinics in eight cities across the country. MPG provides a broad range of medical services from vaccination and occupational services (through its affiliate UAB Endemik) to diagnostic imaging (MRI, CT and X-ray), laboratory, specialist consultations and health checks.

WALLESS Weekly Review

Subscribe and receive the summary of the Lithuanian Supreme Court's rulings every week in your inbox. The information is prepared by the WALLESS Arbitration and Dispute Resolution Team.

Please note that review is in Lithuanian.